Literature DB >> 10892339

Cellular and molecular mechanism of low-turnover osteopenia in the klotho-deficient mouse.

H Kawaguchi1, N Manabe, H Chikuda, K Nakamura, M Kuroo.   

Abstract

The mouse homozygous for a disruption of the klotho locus (KL-/- or klotho mouse) exhibited multiple pathological conditions resembling human aging. We observed osteopenia in KL-/- mice with a low bone turnover, in which the decrease in bone formation exceeded the decrease in bone resorption and resulted in net bone loss. This pathophysiology resembles closely that of senile osteoporosis in humans. Osteoblastic cells from KL-/- mice proliferated normally in vitro; however, they showed much lower alkaline phosphatase activity and mineralized matrix formation than those from control mice. Cultured osteoclastic cells from KL-/- mice had normal resorbing activity and survival rate, but the differentiation of osteoclastic cells from their precursors was significantly disturbed: in the co-culture of osteoblastic cells and osteoclast precursor cells, the formation of tartrate-resistant acid phosphatase-positive multinucleated osteoclastic cells was extremely poor only when osteoclast precursor cells originated from KL-/- mice independently of the origin of the osteoblastic cells. In addition, we found that osteoprotegerin a secreted factor which inhibits osteoclastogenesis, was up-regulated in KL-/- mice. We conclude that a defect in klotho gene expression leads to the independent impairment of osteoblast and osteoclast differentiation, which can be a cause of low-turnover osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10892339     DOI: 10.1007/s000180050037

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  11 in total

Review 1.  Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.

Authors:  Ming Chang Hu; Mingjun Shi; Orson W Moe
Journal:  Pflugers Arch       Date:  2018-12-01       Impact factor: 3.657

Review 2.  Secreted klotho and chronic kidney disease.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 3.  Potential application of klotho in human chronic kidney disease.

Authors:  Javier A Neyra; Ming Chang Hu
Journal:  Bone       Date:  2017-01-20       Impact factor: 4.398

4.  A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.

Authors:  Shoji Ichikawa; Erik A Imel; Mary L Kreiter; Xijie Yu; Donald S Mackenzie; Andrea H Sorenson; Regina Goetz; Moosa Mohammadi; Kenneth E White; Michael J Econs
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

5.  Klotho prevents renal calcium loss.

Authors:  R Todd Alexander; Titia E Woudenberg-Vrenken; Jan Buurman; Henry Dijkman; Bram C J van der Eerden; Johannes P T M van Leeuwen; René J Bindels; Joost G Hoenderop
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

6.  Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice.

Authors:  Christina B Leibrock; Ioana Alesutan; Jakob Voelkl; Diana Michael; Tatsiana Castor; Ursula Kohlhofer; Leticia Quintanilla-Martinez; Laura Kübler; Julia G Mannheim; Bernd J Pichler; Kevin P Rosenblatt; Makoto Kuro-o; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2015-08-27       Impact factor: 4.599

7.  Decreased bone formation and osteopenia in lamin a/c-deficient mice.

Authors:  Wei Li; Li Sze Yeo; Christopher Vidal; Thomas McCorquodale; Markus Herrmann; Diane Fatkin; Gustavo Duque
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

8.  KLOTHO polymorphisms and age-related outcomes in community-dwelling older subjects: The São Paulo Ageing & Health (SPAH) Study.

Authors:  Rosa Maria R Pereira; Thiago Quadrante Freitas; André Silva Franco; Liliam Takayama; Valeria F Caparbo; Diogo S Domiciano; Luana G Machado; Camille P Figueiredo; Paulo R Menezes; Luiz Fernando Onuchic; Isac de Castro
Journal:  Sci Rep       Date:  2020-05-22       Impact factor: 4.379

9.  Klotho upregulates the interaction between RANK and TRAF6 to facilitate RANKL-induced osteoclastogenesis via the NF-κB signaling pathway.

Authors:  Tao Yu; Ce Dou; Yanzhu Lu; Lianli Duan; Jiulin Tan; Jianmei Li; Fei Kang; Shiwu Dong; Yun Bai; Jianzhong Xu
Journal:  Ann Transl Med       Date:  2021-10

Review 10.  Roles of the kidney in the formation, remodeling and repair of bone.

Authors:  Kai Wei; Zhiwei Yin; Yuansheng Xie
Journal:  J Nephrol       Date:  2016-03-04       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.